Pharma Reviews: Sharekhan Maintains 'buy' On These 15 Pharma Names Post Q2 Earnings. Take A Look

Q2FY2022 was a mixed quarter for pharmaceutical companies and revenues, ... Sanofi India | Rating: Buy | LTP: Rs 8,130 | Target: Rs 9,600 ...
Read more: Sharekhan Maintains 'buy' On These 15 Pharma Names Post Q2 Earnings. Take A Look